Cardio-oncology

OCT 11, 2026 · JOURNAL ARTICLE

Nanoparticle-enabled strategies to reduce doxorubicin-induced cardiotoxicity

Cardio-oncology

Doxorubicin (DOX) remains a potent and effective therapy for a broad spectrum of malignancies, including breast cancer, lymphomas, sarcomas, and solid tumors. However, its clinical

OCT 7, 2026 · JOURNAL ARTICLE

Cardio-oncology from the consulting side: diagnostic thresholds, surveillance and treatment responsibility among cardiologists and internists in a German multicentre survey

Cardio-oncology

Abstract Background Cancer therapy-related cardiovascular toxicity (CTR-CVT) is a leading non-cancer cause of morbidity and mortality. The 2022 ESC Guidelines define a multidiscipl

OCT 2, 2026 · JOURNAL ARTICLE

Long-term outcomes of prophylactic cardioprotection in early-stage breast cancer patients on non-anthracycline anti-HER2 therapy

Cardio-oncology

Anti-HER2 therapy has improved survival in HER2-positive breast cancer patients for decades but is associated with well-established cardiotoxicity. Our prior randomized controlled

SEP 29, 2026 · JOURNAL ARTICLE

Patient perspectives on cardioprotective medication during breast cancer treatment

Cardio-oncology

Cardiotoxicity remains a key concern of HER2-directed therapies, with no proven prevention strategies. The success of cardioprotective interventions will depend not only on efficac

SEP 28, 2026 · JOURNAL ARTICLE

Hearts too small for body size after doxorubicin for childhood acute lymphoblastic leukemia: Grinch Syndrome

Cardio-oncology

Cardiovascular disease is a major cause of morbidity and mortality in childhood cancer survivors. We assessed the very long-term cardiac structure and function of adult survivors o

SEP 25, 2026 · JOURNAL ARTICLE

Breast cancer therapy associated changes in thoracic aortic distensibility in those with or without hypertension (UPBEAT WF-97415)

Cardio-oncology

Aortic stiffness or reduced distensibility may contribute to adverse cardiovascular events including myocardial infarction and stroke. This study assessed changes in thoracic ascen

SEP 18, 2026 · JOURNAL ARTICLE

Severe hypertriglyceridemia during adjuvant capecitabine in a patient with factor V Leiden thrombophilia: a case report

Cardio-oncology

Occurrence of Colorectal Cancer (CRC) in patients with pre-existing cardiovascular or thrombotic conditions make oncologic decisions and management strategies significantly challen

SEP 9, 2026 · JOURNAL ARTICLE

Rationale and design of the: breast cancer, fitness and exercise for heart health (BE-FITTER trial)

Cardio-oncology

This is a rationale-and-design paper for a small, single-centre RCT that has not yet reported results; it describes planned methods and hypotheses rather than outcomes.